Design Therapeutics, Inc.盘中异动股价大跌5.28%报6.15美元

市场透视2024-12-27

北京时间2024年12月27日23时20分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速下跌5.28%。截至发稿，该股报6.15美元/股，成交量9377股，换手率0.02%，振幅4.08%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-13.04百万美元，每股收益-0.23美元，毛利-153000.00美元，市盈率-7.31倍。机构评级方面...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2494381097?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-12-27 23:20","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2494381097","market":"us","top_or_hot":-1,"title":"Design Therapeutics, Inc.盘中异动 股价大跌5.28%报6.15美元","media":"市场透视","content":"<div>\n<p>北京时间2024年12月27日23时20分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速下跌5.28%。截至发稿，该股报6.15美元/股，成交量9377股，换手率0.02%，振幅4.08%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-13.04百万美元，每股收益-0.23美元，毛利-153000.00美元，市盈率-7.31倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232051a20c091d&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Design Therapeutics, Inc.盘中异动 股价大跌5.28%报6.15美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nDesign Therapeutics, Inc.盘中异动 股价大跌5.28%报6.15美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-12-27 23:20 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232051a20c091d&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年12月27日23时20分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速下跌5.28%。截至发稿，该股报6.15美元/股，成交量9377股，换手率0.02%，振幅4.08%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-13.04百万美元，每股收益-0.23美元，毛利-153000.00美元，市盈率-7.31倍。机构评级方面...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232051a20c091d&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232051a20c091d&s=b","article_id":"2494381097","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241227232051a20c091d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2494381097","pubTimestamp":1735312851,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年12月27日23时20分，Design Therapeutics, Inc.股票出现异动，股价快速下跌5.28%。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","DSGN":"Design Therapeutics, Inc.","BK4539":"次新股","BK4505":"高瓴资本持仓","LENZ":"Therapeutics"},"translate_title":"Design Therapeutics, Inc. shares fell 5.28% to $6.15 in intraday changes","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LENZ":1,"DSGN":1},"content_text":"北京时间2024年12月27日23时20分，Design Therapeutics, Inc.（DSGN.us）股票出现异动，股价快速下跌5.28%。截至发稿，该股报6.15美元/股，成交量9377股，换手率0.02%，振幅4.08%。最近的财报数据显示，该股实现营业收入0.00美元，净利润-13.04百万美元，每股收益-0.23美元，毛利-153000.00美元，市盈率-7.31倍。机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。Design Therapeutics, Inc.股票所在的生物技术行业中，整体跌幅为0.50%。其相关个股中，Galectin Therapeutics Inc.、Abpro Holdings Inc C/Wts 12/11/2029 (To Pur Com)、Revolution Medicines Inc C/Wts 17/12/2026 (To Pur Com)涨幅较大，Evaxion Biotech As、Scisparc Ltd.、Coeptis Therapeutics Holdings, Inc.较为活跃，换手率分别为99.61%、43.83%、19.94%，振幅较大的相关个股有Galectin Therapeutics Inc.、Cingulate Inc C/Wts 10/12/2026 (To Pur Com)、Moolec Science Sa C/Wts (To Pur Ord)，振幅分别为65.39%、46.32%、45.12%。Design Therapeutics, Inc.公司简介：Design Therapeutics Inc是一家临床阶段的生物制药公司，致力于研究和开发 GeneTAC™ 分子，这是一种新型的针对特定基因的小分子嵌合体治疗候选物，旨在通过解决由遗传核苷酸重复扩展突变引起的疾病的根本原因来改变疾病。公司的产品候选物针对弗里德赖希共济失调症（FA），第二个产品候选物针对 Fuchs 内皮角膜营养不良症（FECD），并且还在推进其 GeneTAC™ 项目以解决其他严重的核苷酸重复驱动的单基因疾病。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.36.0","shortVersion":"4.36.0","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2494381097","isCrawlerRequest":true}

Design Therapeutics, Inc.盘中异动 股价大跌5.28%报6.15美元

精彩评论

Design Therapeutics, Inc.盘中异动股价大跌5.28%报6.15美元